Spondyloarthritis & psoriatic arthritis

An ankylosing spondylitis risk variant alters osteoclast differentiation

Rheumatology (Oxford)Published Case-control study

Main finding · AS onset risk by PSMB1 rs12717 genotypeResult — go to the resultOdds ratio 1.89

Authors' conclusion

These results reveal a novel understanding of the bone formation and reabsorbing imbalance in AS.

Study context

Population
AS patients and controls without rheumatic and arthritis disease
Participants
1,037 vs 1,014
Comparison
AS patients vs controls without rheumatic and arthritis disease
  • ASn = 1,037
  • Controlsn = 1,014reference
Outcome
Association of variants in non-MHC proteasome genes with AS
Methodological detailsgenetic association, functional assays (dual-luciferase reporter, immunoblot, osteoclastogenesis)
  • Genetic association
  • Functional assays (dual-luciferase reporter, immunoblot, osteoclastogenesis)

Main finding

AS onset risk by PSMB1 rs12717 genotype

Odds ratio

1.89

P = 0.0047

As reported in the abstract

Observational data: associations, not effects.

Further findings

HLA-B27 positivity among AS patients

HLA-B27-positive subjects, % of patients
90.0%

Age of AS onset

Main age of AS onset between 16 and 35 years

Original publication

An ankylosing spondylitis risk variant alters osteoclast differentiation. Rheumatology (Oxford). Published 19 September 2022. doi:10.1093/rheumatology/keac542

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.